Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mi | Hedge Fund and Insider Trading News: John Paulson, Steve Cohen, Ray Dalio, Warren Buffett, Dmitry Balyasny, Anthony Scaramucci, Tidan Fund, Irenic Capital Management, MBX Biosciences Inc (MBX), Coinbase Global Inc (COIN), and More | 14 | Insider Monkey | ||
Mi | Tuesday's Insider Trades: Major Buys at MBX Biosciences, Sells at Palantir | 21 | Investing.com | ||
Mi | MBX Biosciences insider purchases $8 million in company stock | 1 | Investing.com | ||
Mi | NEA 17 LP buys $8 million in MBX Biosciences shares | 1 | Investing.com | ||
Mi | OrbiMed executives purchase $12 million of MBX Biosciences stock | 1 | Investing.com | ||
Mi | MBX Biosciences director buys $8 million in company stock | 1 | Investing.com | ||
Mi | MBX Biosciences insider buys $8 million in company stock | 1 | Investing.com | ||
Mi | MBX Biosciences insiders purchase $10 million in stock | 2 | Investing.com | ||
Mi | MBX Biosciences director buys $12 million in company stock | 2 | Investing.com | ||
Mi | MBX Biosciences director buys $10 million in IPO shares | 4 | Investing.com | ||
Mi | MBX Biosciences director buys $12m in company stock | 2 | Investing.com | ||
Mo | MBX Biosciences, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
Mo | MBX Biosciences, Inc.: MBX Biosciences Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares | 36 | GlobeNewswire (Europe) | CARMEL, Ind., Sept. 16, 2024 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX) ("MBX Biosciences"), a clinical-stage biopharmaceutical company focused on the discovery and development of novel... ► Artikel lesen | |
Fr | MBX Biosciences, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
Fr | Bicara, MBX Bio lead gainers as biotech trio makes trading debut | 2 | Seeking Alpha | ||
Fr | MBX Biosciences Opens At $23, IPO Priced At $16 | 2 | Investing.com | ||
Fr | MBX Biosciences shares surge 44% in blockbuster Nasdaq debut | 1 | Reuters | ||
Fr | Zenas, MBX and Bicara all head to Nasdaq in hot day for biotech IPOs | - | FierceBiotech | ||
Fr | MBX Biosciences prices $160M IPO at $16 per share | 2 | Seeking Alpha | ||
Fr | MBX Biosciences Prices IPO Of 10.20 Mln Shares At $16.00/shr | 477 | AFX News | WASHINGTON (dpa-AFX) - MBX Biosciences Inc. (MBX) said that it has priced its initial public offering of 10.20 million shares of its common stock at $16.00 per share.The company noted that it... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
PORTAGE BIOTECH | 9,850 | 0,00 % | Pre-market Movers: Portage Biotech, Veea, Intuitive Machines, Applied Therapeutics, Galmed Pharmaceuticals | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.30 A.M. ET).In the Green Portage Biotech Inc. (PRTG) is up over 179% at... ► Artikel lesen | |
QIAGEN | 41,190 | -0,95 % | BERENBERG stuft QIAGEN NV auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für Qiagen mit einem Kursziel von 54,90 Euro auf "Buy" belassen. Medizintechnik-Unternehmen seien nach dem schwachen Vorjahr... ► Artikel lesen | |
BIONTECH | 104,10 | -7,22 % | BioNTech, First Hydrogen und TSMC mit Paukenschlägen | Das letzte Drittel des bislang erfolgreichen Börsenjahres 2024 läuft, doch die Unsicherheiten und Volatilitäten nehmen zu. So verlor der noch bis vor kurzem als unverwundbar geltende Chipgigant Nvidia... ► Artikel lesen | |
SUMMIT THERAPEUTICS | 24,550 | 0,00 % | ROUNDUP/Aktien New York: Neue Rekorde vor US-Zinsentscheid | NEW YORK (dpa-AFX) - Vor dem Zinsentscheid der US-Notenbank Fed bleiben die Anleger an den New Yorker Börsen optimistisch. Der Leitindex Dow Jones Industrial markierte am Dienstag gleich zu Beginn... ► Artikel lesen | |
ADMA BIOLOGICS | 19,300 | +3,18 % | ADMA Biologics, Inc.: ADMA Biologics Set to Join S&P SmallCap 600 Index | RAMSEY, N.J. and BOCA RATON, Fla., Sept. 17, 2024 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) ("ADMA"), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing... ► Artikel lesen | |
AVIDITY BIOSCIENCES | 44,620 | 0,00 % | Unveiling 7 Analyst Insights On Avidity Biosciences | ||
EVOTEC | 6,460 | -0,39 % | Bayer, BMW, Deutsche Bank, Evotec, Rheinmetall - 4investors Aktien Top-News | Wo ist am Aktienmarkt etwas los, welche Themen interessieren Anleger derzeit besonders? Vor allem für Trader ist es wichtig zu wissen, wo "die Musik spielt" und welche Themen an der Börse aktuell besonders... ► Artikel lesen | |
MODERNA | 62,95 | -2,82 % | Ihre wichtigsten Termine: Alle Analysten-Augen auf: Moderna, Ryanair, Adobe, Fraport und Baloise | © Foto: Bodo Schackow/dpaGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine 07:00... ► Artikel lesen | |
MOONLAKE IMMUNOTHERAPEUTICS | 53,21 | 0,00 % | H.C. Wainwright bekräftigt Kaufempfehlung für Moonlake Immunotherapeutics-Aktie | ||
EDGEWISE THERAPEUTICS | 19,040 | 0,00 % | Edgewise präsentiert Daten aus Phase-1- und -2-Studien für Herzmedikament | ||
NUVALENT | 102,76 | 0,00 % | Nuvalent Stock Moves Up 20% in a Week: What's Driving the Rally? | ||
ARRIVENT BIOPHARMA | 23,580 | -1,75 % | ArriVent BioPharma, Inc.: ArriVent BioPharma Reports Second Quarter 2024 Financial Results | Clinical proof-of-concept monotherapy data for once daily, first-line firmonertinib in EGFR PACC mutant non-small cell lung cancer (NSCLC) to be presented as a presidential symposium presentation... ► Artikel lesen | |
RECURSION PHARMACEUTICALS | 6,900 | 0,00 % | Looking Into Recursion Pharmaceuticals' Recent Short Interest | ||
ARCELLX | 80,55 | 0,00 % | Arcellx CFO Michelle Gilson sells shares worth over $1.1 million | ||
LONGBOARD PHARMACEUTICALS | 29,310 | +6,74 % | Baird maintains Outperform rating on Longboard Pharmaceuticals stock with steady price target |